Possible mechanisms of allogeneic blood transfusion-associated postoperative infection

被引:125
|
作者
Vamvakas, EC
机构
[1] NYU, Med Ctr, Blood Bank, New York, NY 10016 USA
[2] NYU, Med Ctr, Transfus Serv, New York, NY 10016 USA
[3] NYU, Sch Med, Dept Pathol, New York, NY USA
关键词
D O I
10.1053/tmrv.2002.31463
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Four possible mechanisms have been reported to underlie the apparent association of allogeneic blood transfusion (ABT) with postoperative bacterial infection. These are (1) a transfusion-related immunomodulatory (TRIM) effect of ABT mediated by immunologically active allogeneic white blood cells (WBCs) that downregulate the recipient's immune function, thereby predisposing to infection; (2) a TRIM effect of ABT mediated by soluble biologic response modifiers released in a time-dependent manner from WBC granules or membranes into the supernatant fluid of red blood cells (RBCs) during storage; (3) a TRIM effect of ABT mediated by soluble HLA peptides that circulate in allogeneic plasma; and (4) a related non-TRIM effect of ABT, whereby ABT causes postoperative organ dysfunction that predisposes to infection. The available clinical studies examining the association of ABT with postoperative infection were not designed to specifically test 1 or more of these 4 hypotheses. Thus, it is difficult to make inferences from the published data about the specific mechanism(s) that may underlie the purported association of ABT with infection. To permit such inferences, future studies of the association of ABT with postoperative infection should consider 2 outcomes (ie, postoperative organ dysfunction in addition to postoperative infection), as well as 3 possible exposures (ie, allogeneic WBCs, soluble biologic response modifiers originating in WBC granules or membranes, and/or soluble HLA molecules circulating in allogeneic plasma). Copyright 2002, Elsevier Science (USA). All rights reserved.
引用
收藏
页码:144 / 160
页数:17
相关论文
共 50 条
  • [41] Safety of filtered leukocyte-reduced blood products for prevention of transfusion-associated cytomegalovirus infection - Response
    Bowden, RA
    Slichter, S
    Sayers, M
    Weisdorf, D
    Fisher, L
    BLOOD, 1996, 87 (11) : 4910 - 4911
  • [42] Transfusion-associated falciparum malaria successfully treated with red blood cell exchange transfusion
    Tejura, B
    Sass, DA
    Fischer, RA
    Daskal, I
    Eiger, G
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 320 (05): : 337 - 341
  • [43] TRANSFUSION-ASSOCIATED CYTOMEGALOVIRUS INFECTIONS
    ADLER, SP
    REVIEWS OF INFECTIOUS DISEASES, 1983, 5 (06): : 977 - 993
  • [44] REPORTING TRANSFUSION-ASSOCIATED HEPATITIS
    GRINDON, AJ
    ROSVOLL, RV
    TRANSFUSION, 1980, 20 (01) : 108 - 109
  • [45] Blood transfusion and postoperative wound infection.
    Vamvakas, EC
    Carven, JH
    TRANSFUSION, 1997, 37 (09) : S336 - S336
  • [46] A TRANSFUSION-ASSOCIATED CASE OF BABESIOSIS
    Washburn, R.
    Ong, M.
    Nanchahal, D.
    Todd, J.
    Cotelingham, J.
    Rafeek, H.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 497 - 497
  • [47] Transfusion-associated circulatory overload
    Ozier, Y.
    Mouquet, F.
    Rieux, C.
    Mertes, P. -M.
    Muller, J. -Y.
    Caldani, C.
    Boudjedir, K.
    Carlier, M.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2012, 19 (4-5) : 263 - 269
  • [48] Transfusion-associated malaria - Reply
    Zucker, JR
    Kachur, SP
    EMERGING INFECTIOUS DISEASES, 1996, 2 (02) : 152 - 152
  • [49] Transfusion-associated chest pain
    Murphy, Colin
    Parakh, Rugvedita
    Metcalf, Ryan
    Pagano, Monica B.
    TRANSFUSION, 2019, 59 (02) : 463 - 469
  • [50] TRANSFUSION-ASSOCIATED HEPATITIS AND AIDS
    DREW, SI
    AVOY, DR
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (03): : 183 - 184